Automatic detection of preclinical neurodegeneration
Authors:
- S. KlöppelSKS. Klöppel
- C. ChuCCC. Chu
- G. C. TanGTG. C. Tan
- B. DraganskiBDB. Draganski
- H. JohnsonHJH. Johnson
- J. S. PaulsenJPJ. S. Paulsen
- W. KienzleWKW. Kienzle
- S. J. TabriziSTS. J. Tabrizi
- J. AshburnerJAJ. Ashburner
- R.S.J. FrackowiakRFR.S.J. Frackowiak
- PREDICT-HD Investigators of the Huntington Study GroupPGPREDICT-HD Investigators of the Huntington Study Group
- 3 February 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 72 (5) , 426-431
Abstract
Treatment of neurodegenerative diseases is likely to be most beneficial in the very early, possibly preclinical stages of degeneration. We explored the usefulness of fully automatic structural MRI classification methods for detecting subtle degenerative change. The availability of a definitive genetic test for Huntington disease (HD) provides an excellent metric for judging the performance of such methods in gene mutation carriers who are free of symptoms. Using the gray matter segment of MRI scans, this study explored the usefulness of a multivariate support vector machine to automatically identify presymptomatic HD gene mutation carriers (PSCs) in the absence of any a priori information. A multicenter data set of 96 PSCs and 95 age- and sex-matched controls was studied. The PSC group was subclassified into three groups based on time from predicted clinical onset, an estimate that is a function of DNA mutation size and age. Subjects with at least a 33% chance of developing unequivocal signs of HD in 5 years were correctly assigned to the PSC group 69% of the time. Accuracy improved to 83% when regions affected by the disease were selected a priori for analysis. Performance was at chance when the probability of developing symptoms in 5 years was less than 10%. Presymptomatic Huntington disease gene mutation carriers close to estimated diagnostic onset were successfully separated from controls on the basis of single anatomic scans, without additional a priori information. Prior information is required to allow separation when degenerative changes are either subtle or variable.Keywords
This publication has 27 references indexed in Scilit:
- Detection of Huntington's disease decades before diagnosis: the Predict-HD studyJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Onset and rate of striatal atrophy in preclinical Huntington diseaseNeurology, 2004
- A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG lengthClinical Genetics, 2004
- Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 TNeuroImage, 2004
- Morphological classification of brains via high-dimensional shape transformations and machine learning methodsNeuroImage, 2004
- The distribution of structural neuropathology in pre-clinical Huntington's diseaseBrain, 2002
- Voxel-Based Morphometry—The MethodsNeuroImage, 2000
- Two-sided confidence intervals for the single proportion: comparison of seven methodsStatistics in Medicine, 1998
- Unified Huntington's disease rating scale: Reliability and consistencyMovement Disorders, 1996
- A Voxel-Based Method for the Statistical Analysis of Gray and White Matter Density Applied to SchizophreniaNeuroImage, 1995